The benefits of the multi-target approach in drug design and discovery

Promiscuous binding has been considered to be a problem in the design and development of new drugs against a given disease. However, promiscuity in Molecular recognition is not all bad news, and scientists are currently taking advantage of the emerging 'promiscuous binding' or 'multi-target approach' in medicinal chemistry. (c) 2005 Elsevier Ltd. All rights reserved.